Paras Healthcare shares: After IPO listing gains, check what’s happening with stock - Buy, sell or hold?Experts weigh in

Paras Healthcare shares rose 5.4% to a record ₹777 after an early dip, following a market debut at a 3.9% premium to its ₹693 IPO price. Choice Institutional Equities initiated coverage with a Buy rating and ₹900 target, citing growth in specialised care and operational improvements.

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to livemint.com's own reporting rather than reproducing it — the excerpt above comes from livemint.com's own feed.